Alma Hybrid Launches

Alma Hybrid™, the first laser platform to include an ablative 10,600nm (CO₂) laser and a non-ablative 1570nm laser for skin resurfacing, in launching in the US. The system received FDA 510(k) clearance. 

Alma Hybrid offers physicians a comprehensive solution to utilize each best-in-class laser independently or for the very first time, customize the treatment pattern by combining both wavelengths. HyGrid™ introduces an entirely new injury pattern unseen with any other device on the market, the company says. 

Alma Hybrid is the only device to feature high performance delivery known as HyPer™. In HyPer delivery, an ablative CO₂ injury is followed by a non-ablative 1570nm injury in random pattern, significantly reducing treatment time and improving patient experience.

"The combination of an ablative CO₂ laser and a non-ablative 1570nm laser in one platform already makes Alma Hybrid unique. But the unmatched level of flexibility and customization makes this device the ultimate resurfacing tool," says Jeffrey Hsu, MD, a dermatologist at Oak Dermatology, in the greater Chicago area. "I can fly through a full-face skin resurfacing treatment in 15 minutes with HyPer™ delivery, and the synergy of CO₂ and 1570nm gives me the best possible combination of effectiveness and safety." 

"Alma has a long-established track record of developing radically innovative solutions such as Alma Hybrid to the market," says Keith Adams, President of Alma, North America. "We're committed in advancing our industry forward by investing in essential treatment categories that our customers and their patients depend on, like skin resurfacing."